Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway

Pei Yu Chen, Jui Sheng Sun, Yang Hwei Tsuang, Ming Hong Chen, Pei Wei Weng, Feng Huei Lin

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which catalyzes the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a rate-limiting step in cholesterol synthesis. Statins are able to reduce cardiovascular risk in hypercholesterolemic patients. In recent years, the possible effect of statins on bone tissue has received particular attention. The present study was undertaken to understand the events of osteoblast differentiation induced by statins. Our hypothesis is that simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/bone morphogenic protein (BMP)-2 signaling pathway. The viability and differentiation of osteoblasts were examined by mitochondrial activity assay, alkaline phosphatase (ALP) activity, and gene expression. The associated signaling pathways were analyzed by cytoplasmic and membrane proteins manifestation. After administration of 10-6 M simvastatin, the ALP activity was significantly enhanced, and the expression of BMP-2, ALP, sialoprotein, and type I collagen genes were up-regulated. After simvastatin treatment, both the RasGRF1 and phospho-RasGRF1 in the cytoplasm decreased significantly, whereas those on the plasma membrane increased. A marked increase in membranous GAP-associated protein (P190) and the activated form of both phospho-extracellular signal-regulated kinase1/2 and phospho-Smad1 were also noted. In conclusion, this study shows that statins pose a positive effect on the metabolism of osteoblasts. Simvastatin can promote osteoblast viability and differentiation via membrane-bound Ras/Smad/Erk/BMP-2 pathway. Statins stimulate osteoblast differentiation in vitro and may be a promising drug for the treatment of osteoporosis in the future.

Original languageEnglish
Pages (from-to)191-199
Number of pages9
JournalNutrition Research
Volume30
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin
Osteoblasts
Bone and Bones
Alkaline Phosphatase
Proteins
Cell Membrane
Sialoglycoproteins
GTPase-Activating Proteins
Mevalonic Acid
Collagen Type I
Osteoporosis
Oxidoreductases
Membrane Proteins
Cytoplasm
Cholesterol
Gene Expression
Membranes
Therapeutics
Pharmaceutical Preparations

Keywords

  • Alkaline phosphatase
  • Collagen type1
  • GAPs
  • GEFs
  • Osteoblasts
  • Ras/Smad/Erk/BMP-2
  • Simvastatin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. / Chen, Pei Yu; Sun, Jui Sheng; Tsuang, Yang Hwei; Chen, Ming Hong; Weng, Pei Wei; Lin, Feng Huei.

In: Nutrition Research, Vol. 30, No. 3, 03.2010, p. 191-199.

Research output: Contribution to journalArticle

Chen, Pei Yu ; Sun, Jui Sheng ; Tsuang, Yang Hwei ; Chen, Ming Hong ; Weng, Pei Wei ; Lin, Feng Huei. / Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. In: Nutrition Research. 2010 ; Vol. 30, No. 3. pp. 191-199.
@article{2b1ad5ee56f14ac59d210fbf0324c62a,
title = "Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway",
abstract = "Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which catalyzes the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a rate-limiting step in cholesterol synthesis. Statins are able to reduce cardiovascular risk in hypercholesterolemic patients. In recent years, the possible effect of statins on bone tissue has received particular attention. The present study was undertaken to understand the events of osteoblast differentiation induced by statins. Our hypothesis is that simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/bone morphogenic protein (BMP)-2 signaling pathway. The viability and differentiation of osteoblasts were examined by mitochondrial activity assay, alkaline phosphatase (ALP) activity, and gene expression. The associated signaling pathways were analyzed by cytoplasmic and membrane proteins manifestation. After administration of 10-6 M simvastatin, the ALP activity was significantly enhanced, and the expression of BMP-2, ALP, sialoprotein, and type I collagen genes were up-regulated. After simvastatin treatment, both the RasGRF1 and phospho-RasGRF1 in the cytoplasm decreased significantly, whereas those on the plasma membrane increased. A marked increase in membranous GAP-associated protein (P190) and the activated form of both phospho-extracellular signal-regulated kinase1/2 and phospho-Smad1 were also noted. In conclusion, this study shows that statins pose a positive effect on the metabolism of osteoblasts. Simvastatin can promote osteoblast viability and differentiation via membrane-bound Ras/Smad/Erk/BMP-2 pathway. Statins stimulate osteoblast differentiation in vitro and may be a promising drug for the treatment of osteoporosis in the future.",
keywords = "Alkaline phosphatase, Collagen type1, GAPs, GEFs, Osteoblasts, Ras/Smad/Erk/BMP-2, Simvastatin",
author = "Chen, {Pei Yu} and Sun, {Jui Sheng} and Tsuang, {Yang Hwei} and Chen, {Ming Hong} and Weng, {Pei Wei} and Lin, {Feng Huei}",
year = "2010",
month = "3",
doi = "10.1016/j.nutres.2010.03.004",
language = "English",
volume = "30",
pages = "191--199",
journal = "Nutrition Research",
issn = "0271-5317",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway

AU - Chen, Pei Yu

AU - Sun, Jui Sheng

AU - Tsuang, Yang Hwei

AU - Chen, Ming Hong

AU - Weng, Pei Wei

AU - Lin, Feng Huei

PY - 2010/3

Y1 - 2010/3

N2 - Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which catalyzes the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a rate-limiting step in cholesterol synthesis. Statins are able to reduce cardiovascular risk in hypercholesterolemic patients. In recent years, the possible effect of statins on bone tissue has received particular attention. The present study was undertaken to understand the events of osteoblast differentiation induced by statins. Our hypothesis is that simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/bone morphogenic protein (BMP)-2 signaling pathway. The viability and differentiation of osteoblasts were examined by mitochondrial activity assay, alkaline phosphatase (ALP) activity, and gene expression. The associated signaling pathways were analyzed by cytoplasmic and membrane proteins manifestation. After administration of 10-6 M simvastatin, the ALP activity was significantly enhanced, and the expression of BMP-2, ALP, sialoprotein, and type I collagen genes were up-regulated. After simvastatin treatment, both the RasGRF1 and phospho-RasGRF1 in the cytoplasm decreased significantly, whereas those on the plasma membrane increased. A marked increase in membranous GAP-associated protein (P190) and the activated form of both phospho-extracellular signal-regulated kinase1/2 and phospho-Smad1 were also noted. In conclusion, this study shows that statins pose a positive effect on the metabolism of osteoblasts. Simvastatin can promote osteoblast viability and differentiation via membrane-bound Ras/Smad/Erk/BMP-2 pathway. Statins stimulate osteoblast differentiation in vitro and may be a promising drug for the treatment of osteoporosis in the future.

AB - Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which catalyzes the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a rate-limiting step in cholesterol synthesis. Statins are able to reduce cardiovascular risk in hypercholesterolemic patients. In recent years, the possible effect of statins on bone tissue has received particular attention. The present study was undertaken to understand the events of osteoblast differentiation induced by statins. Our hypothesis is that simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/bone morphogenic protein (BMP)-2 signaling pathway. The viability and differentiation of osteoblasts were examined by mitochondrial activity assay, alkaline phosphatase (ALP) activity, and gene expression. The associated signaling pathways were analyzed by cytoplasmic and membrane proteins manifestation. After administration of 10-6 M simvastatin, the ALP activity was significantly enhanced, and the expression of BMP-2, ALP, sialoprotein, and type I collagen genes were up-regulated. After simvastatin treatment, both the RasGRF1 and phospho-RasGRF1 in the cytoplasm decreased significantly, whereas those on the plasma membrane increased. A marked increase in membranous GAP-associated protein (P190) and the activated form of both phospho-extracellular signal-regulated kinase1/2 and phospho-Smad1 were also noted. In conclusion, this study shows that statins pose a positive effect on the metabolism of osteoblasts. Simvastatin can promote osteoblast viability and differentiation via membrane-bound Ras/Smad/Erk/BMP-2 pathway. Statins stimulate osteoblast differentiation in vitro and may be a promising drug for the treatment of osteoporosis in the future.

KW - Alkaline phosphatase

KW - Collagen type1

KW - GAPs

KW - GEFs

KW - Osteoblasts

KW - Ras/Smad/Erk/BMP-2

KW - Simvastatin

UR - http://www.scopus.com/inward/record.url?scp=77952285581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952285581&partnerID=8YFLogxK

U2 - 10.1016/j.nutres.2010.03.004

DO - 10.1016/j.nutres.2010.03.004

M3 - Article

VL - 30

SP - 191

EP - 199

JO - Nutrition Research

JF - Nutrition Research

SN - 0271-5317

IS - 3

ER -